Abingdon Health is a UK-based diagnostics group focused on developing, manufacturing and commercialising immunoassay tests and reader systems. We provide lateral flow assay development and manufactur...
Abingdon Health is a UK-based diagnostics group focused on developing, manufacturing and commercialising immunoassay tests and reader systems. We provide lateral flow assay development and manufacturing services for customers looking to develop new assays or looking to transfer existing laboratory-based assays to a lateral flow format. We take projects from initial concept all the way through to routine and large-scale manufacturing. We also offer routine manufacturing services for customers looking to transfer a lateral flow test already in routine manufacture to new lateral flow manufacturing partners. In addition, we offer lateral flow reader assay OEM solutions. Based on our CE marked and FDA registered touch-screen reader, ADxLR5®, we carry out reader customisation for customers looking for a quantitative solution for a lateral flow assay. Our development and manufacturing services are available to customers working in all industry sectors such as healthcare, pharma, animal health, agri-food and plant health sectors Our lateral flow assay manufacturing facility in York is certified to ISO13485:2003 (including EN ISO 13485:2012) and is GMP compliant with the U.S. Food and Drug Administration (FDA). We use advanced automated lateral flow manufacturing and assembly equipment, all of which is housed in environmentally controlled laboratories in order to produce the highest quality product. We have developed and commercialised our own rapid tests for haematology oncology specifically in the area of B-cell dyscrasias. The Seralite® Free Light Chain product range is used as an aid in the diagnosis and management of multiple myeloma. To support our strategic plan we are currently developing a multiplexed immunoassay rapid testing system based on fully disposable medical diagnostics for the rapid testing market. Social Media disclaimer: https://goo.gl/4su5QC